Acasti Pharma Inc Share Price Toronto S.E.
Equities
APO
CA00430K1057
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- CAD | - |
|
21/06 | Acasti Pharma Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
28/05 | Acasti Pharma Inc. to Attend BIO International Convention 2024 | CI |
Sales 2025 * | - | Sales 2026 * | 1.21M 884K 73.95M | Capitalization | 39.79M 29.08M 2.43B |
---|---|---|---|---|---|
Net income 2025 * | -23M -16.81M -1.41B | Net income 2026 * | -25M -18.27M -1.53B | EV / Sales 2025 * | - |
Net cash position 2025 * | - 0 0 | Net cash position 2026 * | - 0 0 | EV / Sales 2026 * | 32.9 x |
P/E ratio 2025 * |
-2.81
x | P/E ratio 2026 * |
-3.09
x | Employees | - |
Yield 2025 * |
-
| Yield 2026 * |
-
| Free-Float | 83.98% |
Latest transcript on Acasti Pharma Inc
Managers | Title | Age | Since |
---|---|---|---|
Prashant Kohli
CEO | Chief Executive Officer | 52 | 01/21/01 |
Director of Finance/CFO | 52 | 05/01 | |
Carrie D'Andrea
CTO | Chief Tech/Sci/R&D Officer | 52 | 08/23/08 |
Members of the board | Title | Age | Since |
---|---|---|---|
A. Davis
BRD | Director/Board Member | 57 | 10/23/10 |
Director/Board Member | - | 10/23/10 | |
Santosh Kottayil
BRD | Director/Board Member | 60 | 10/23/10 |
1st Jan change | Capi. | |
---|---|---|
+55.19% | 815B | |
+45.28% | 654B | |
-6.09% | 354B | |
+21.92% | 337B | |
+18.85% | 247B | |
+3.23% | 229B | |
+13.76% | 219B | |
+10.86% | 171B | |
-2.78% | 159B |
- Stock Market
- Equities
- ACST Stock
- APO Stock